Alembic gets USFDA nod for Silodosin capsules

Alembic Pharmaceuticals on Tuesday said it has received final approval from the US health regulator for its generic Silodosin capsules used in treatment of benign prostatic hyperplasia.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news